The 9 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 120.00, with a high estimate of 150.00 and a low estimate of 85.00. The median estimate represents a +52.71% increase from the last price of 78.58.
The current consensus among 11 polled investment analysts is to Buy stock in Beam Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.97
Reporting Date Apr 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.